Fabian Fellipe Bueno Lemos

Mr. Fabian Fellipe Bueno Lemos

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2023 in Viruses
Verified
Journal Article
Open access
PDF file
QFQesya Rodrigues Ferreira
Qesya Rodrigues Ferreira
FLFabian Fellipe Bueno Lemos
Fabian Fellipe Bueno Lemos
MMMatheus Moura
Matheus Moura
JNJéssica Oliveira de Souza Nascimento
Jéssica Oliveira de Souza Nascimento
ANAna Flávia Novaes
Ana Flávia Novaes
FMFabrício De melo
Fabrício De melo
Aedes aegypti and Aedes albopictus are the vectors of important arboviruses: dengue fever, chikungunya, Zika, and yellow fever. Female mosquitoes acquire arboviruses by feeding on the infected host blood, thus being able to transmit it to their offspring. The intrinsic ability of a vector to infect itself and transmit a pathogen is known as vector competence. Several factors influence the susceptibility of these females to be infected by these arboviruses, such as the activation of the innate immune system through the Toll, immunodeficiency (Imd), JAK-STAT pathways, and the interference of specific antiviral response pathways of RNAi. It is also believed that the presence of non-pathogenic microorganisms in the microbiota of these arthropods could influence this immune response, as it provides a baseline activation of the innate immune system, which may generate resistance against arboviruses. In addition, this microbiome has direct action against arboviruses, mainly due to the ability of Wolbachia spp. to block viral genome replication, added to the competition for resources within the mosquito organism. Despite major advances in the area, studies are still needed to evaluate the microbiota profiles of Aedes spp. and their vector competence, as well as further exploration of the individual roles of microbiome components in activating the innate immune system.

1 January 2025 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PLPedro Henrique Melo Lima
Pedro Henrique Melo Lima
CLCaio Ferraz Lopes
Caio Ferraz Lopes
JFJoão Pedro Camargo Freire
João Pedro Camargo Freire
LFLucas Dias Feliciano
Lucas Dias Feliciano
RARebeca Cristina Oliveira Amorim
Rebeca Cristina Oliveira Amorim
FMFabrício De melo
Fabrício De melo
Acinetobacter baumannii is a gram-negative opportunistic pathogen associated with high morbidity and mortality in nosocomial infections, particularly in intensive care units. Multidrug resistance (MDR) is mediated by efflux pumps, lipopolysaccharide modifications, aminoglycoside adenylyltransferases, FosA, structural alterations, and production of enzymes that inactivate antibiotics, such as carbapenemases. These factors limit the therapeutic options and increase clinical challenges, as there are currently few drugs or combinations with therapeutic success against A. baumannii infections. Some strategies and new drugs, such as cefiderocol, eravacycline, sulbactam-darlobactam, tigecycline, and their combinations with colistin, are being tested and have shown apparent advances. This integrative review discusses the current resistance mechanisms and emerging therapeutic strategies aimed at overcoming the growing threat posed by MDR A. baumannii.